Skip to search formSkip to main contentSkip to account menu

pleconaril

Known as: 3-(3,5-dimethyl-4((3-(3-methyl-5-isoxazolyl)propyl)phenyl)-5-trifluoromethyl)-1,2,4-oxadiazole, 3-[3,5-Dimethyl-4-[3-(3-Methyl-5-Isoxazolyl)Propoxy]Phenyl]-5-(Trifluoromethyl)-1,2,4-Oxadiazole 
A small-molecule inhibitor with activity against viruses in the picornaviridae family, including enterovirus and rhinovirus. Pleconaril binds to a… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease that primarily attacks motor neurons in the brain… 
Highly Cited
2003
Highly Cited
2003
Abstract The novel capsid-binding antiviral pleconaril inhibits in vitro replication of most rhinoviruses and enteroviruses. Oral… 
Highly Cited
2001
Highly Cited
2001
Enteroviruses usually cause self-limited disease that, although associated with high morbidity, is rarely fatal. In certain… 
Highly Cited
2001
Highly Cited
2001
Pleconaril (VP-63843) 3-[3,5-dimethyl-4[[3-(3-methyl-5-isoxazolyl)propyl] oly]phenyl]-5-(trifluoromethyl)-1,2,4-oxadiazole is a… 
Highly Cited
2000
Highly Cited
2000
A randomized, double-blind study assessed the efficacy and safety of pleconaril, a novel antiviral drug with broad-spectrum… 
2000
2000
BACKGROUND Pleconaril is an orally active, broad spectrum antipicornaviral agent with activity against nonpolio enteroviruses… 
Highly Cited
1999
Highly Cited
1999
ABSTRACT The activity of pleconaril in cell culture against prototypic enterovirus strains and 215 clinical isolates of the most… 
Highly Cited
1999
Highly Cited
1999
Pleconaril (VP 63843) is a novel orally bioavailable small molecule with broad antipicornavirus (enterovirus and rhinovirus…